$TOUR
Tuniu Corp

2023 Q4 Form 20-F Financial Statement

#000110465924053505 Filed on April 29, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $62.15M
YoY Change 133.45%
Cost Of Revenue $20.79M
YoY Change 52.41%
Gross Profit $41.37M
YoY Change 218.56%
Gross Profit Margin 66.56%
Selling, General & Admin $32.53M
YoY Change 5.55%
% of Gross Profit 78.63%
Research & Development $8.025M
YoY Change 8.96%
% of Gross Profit 19.4%
Depreciation & Amortization $1.675M
YoY Change -24.79%
% of Gross Profit 4.05%
Operating Expenses $55.71M
YoY Change 28.19%
Operating Profit -$14.35M
YoY Change -52.92%
Interest Expense $496.0K
YoY Change -30.34%
% of Operating Profit
Other Income/Expense, Net $1.001M
YoY Change 12.47%
Pretax Income -$13.96M
YoY Change -52.82%
Income Tax $203.0K
% Of Pretax Income
Net Earnings -$13.99M
YoY Change -50.11%
Net Earnings / Revenue -22.5%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share -$0.04
COMMON SHARES
Basic Shares Outstanding 371.5M
Diluted Shares Outstanding 371.5M

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $53.38M
Short-Term Investments
Other Short-Term Assets $1.686M
YoY Change -44.01%
Inventory
Prepaid Expenses
Receivables $5.864M
Other Receivables $1.340M
Total Short-Term Assets $212.4M
YoY Change 22.09%
LONG-TERM ASSETS
Property, Plant & Equipment $8.096M
YoY Change -34.45%
Goodwill $0.00
YoY Change -100.0%
Intangibles $3.675M
YoY Change -17.36%
Long-Term Investments $7.723M
YoY Change -2.02%
Other Assets $7.882M
YoY Change -40.32%
Total Long-Term Assets $63.71M
YoY Change -35.18%
TOTAL ASSETS
Total Short-Term Assets $212.4M
Total Long-Term Assets $63.71M
Total Assets $276.1M
YoY Change 1.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.66M
YoY Change 17.63%
Accrued Expenses
YoY Change
Deferred Revenue $38.06M
YoY Change 165.4%
Short-Term Debt $1.025M
YoY Change -5.96%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $135.1M
YoY Change 20.31%
LONG-TERM LIABILITIES
Long-Term Debt $1.464M
YoY Change -15.57%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.066M
YoY Change -53.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $135.1M
Total Long-Term Liabilities $3.066M
Total Liabilities $138.1M
YoY Change 16.24%
SHAREHOLDERS EQUITY
Retained Earnings -$1.145B
YoY Change -85.74%
Common Stock $1.287B
YoY Change -2.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $145.2M
YoY Change
Total Liabilities & Shareholders Equity $276.1M
YoY Change 1.42%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$13.99M
YoY Change -50.11%
Depreciation, Depletion And Amortization $1.675M
YoY Change -24.79%
Cash From Operating Activities $232.8M
YoY Change -262.83%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $5.765M
YoY Change -176.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.181M
YoY Change 4444.29%
NET CHANGE
Cash From Operating Activities 232.8M
Cash From Investing Activities 5.765M
Cash From Financing Activities -3.181M
Net Change In Cash 34.79M
YoY Change -221.37%
FREE CASH FLOW
Cash From Operating Activities $232.8M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001597095
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 us-gaap Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration
GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet
CY2022 us-gaap Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration
GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet
CY2023 us-gaap Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration
GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
389331543
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
389331543
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
48700000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
389331543
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-36430
CY2023 dei Entity Registrant Name
EntityRegistrantName
Tuniu Corp
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
6, 8-12th floor, building 6-A, Juhuiyuan
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
NO. 108 Xuanwudadao
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
Xuanwu District
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Nanjing
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
210023
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
1424
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers Zhong Tian LLP
CY2023 dei Auditor Location
AuditorLocation
Shanghai
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153835000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
378989000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53379000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
44052000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
65902000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9282000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
724413000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
777890000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
109564000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33644000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41633000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5864000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1030000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
9515000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1340000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
242994000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
234189000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32985000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1199968000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1508118000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
212414000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
230562000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
209819000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
29552000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85182000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57479000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8096000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30672000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26091000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3675000
CY2022Q4 tour Land Use Rights Net
LandUseRightsNet
92590000
CY2023Q4 tour Land Use Rights Net
LandUseRightsNet
90529000
CY2023Q4 tour Land Use Rights Net
LandUseRightsNet
12751000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33204000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12484000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1758000
CY2022Q4 us-gaap Goodwill
Goodwill
114661000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91091000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55960000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7882000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
677962000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
452362000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
63714000
CY2022Q4 us-gaap Assets
Assets
1877930000
CY2023Q4 us-gaap Assets
Assets
1960480000
CY2023Q4 us-gaap Assets
Assets
276128000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
7517000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
7277000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1025000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
261873000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
317104000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44663000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4710000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6405000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
902000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26507000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21401000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3014000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4047000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4305000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
606000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
98899000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
270197000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
38056000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12439000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2709000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
382000
CY2022Q4 tour Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
358312000
CY2023Q4 tour Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
329481000
CY2023Q4 tour Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
46408000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
774304000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
958879000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
135056000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26482000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5348000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
753000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6839000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6027000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
849000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11959000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10395000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1464000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
45280000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
21770000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3066000
CY2022Q4 us-gaap Liabilities
Liabilities
819584000
CY2023Q4 us-gaap Liabilities
Liabilities
980649000
CY2023Q4 us-gaap Liabilities
Liabilities
138122000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27200000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27200000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
3831000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
389331543
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
389331543
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
249000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
249000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
35000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
17951931
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
17800446
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
288600000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
285983000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
40280000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
9125655000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
9138720000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1287162000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
298981000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
305416000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
43017000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8028261000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8127552000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1144742000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1108024000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1030850000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
145192000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-76878000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-78219000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-11017000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1031146000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
952631000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134175000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1877930000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1960480000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
276128000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
426348000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
183620000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
441270000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62151000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
254815000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94066000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
147581000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20786000
CY2021 us-gaap Gross Profit
GrossProfit
171533000
CY2022 us-gaap Gross Profit
GrossProfit
89554000
CY2023 us-gaap Gross Profit
GrossProfit
293689000
CY2023 us-gaap Gross Profit
GrossProfit
41365000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54622000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50799000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56974000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8025000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
150493000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
103617000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
117706000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16579000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
174021000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
108935000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
113221000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15947000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
112102000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
114661000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16150000
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
26064000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
75685000
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
7009000
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
987000
CY2021 us-gaap Operating Expenses
OperatingExpenses
353072000
CY2022 us-gaap Operating Expenses
OperatingExpenses
299768000
CY2023 us-gaap Operating Expenses
OperatingExpenses
395553000
CY2023 us-gaap Operating Expenses
OperatingExpenses
55714000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-181539000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-210214000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-101864000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-14349000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
50041000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
27181000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
5689000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
801000
CY2021 us-gaap Interest Expense
InterestExpense
7491000
CY2022 us-gaap Interest Expense
InterestExpense
4912000
CY2023 us-gaap Interest Expense
InterestExpense
3525000
CY2023 us-gaap Interest Expense
InterestExpense
496000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7030000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-22210000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6483000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-913000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2895000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6136000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7107000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1001000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-129064000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-204019000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-99076000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13956000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
130000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-731000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1441000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
203000
CY2021 tour Income Loss From Equity Method Investment
IncomeLossFromEquityMethodInvestment
726000
CY2022 tour Income Loss From Equity Method Investment
IncomeLossFromEquityMethodInvestment
292000
CY2023 tour Income Loss From Equity Method Investment
IncomeLossFromEquityMethodInvestment
-580000
CY2023 tour Income Loss From Equity Method Investment
IncomeLossFromEquityMethodInvestment
-82000
CY2021 us-gaap Profit Loss
ProfitLoss
-128468000
CY2022 us-gaap Profit Loss
ProfitLoss
-202996000
CY2023 us-gaap Profit Loss
ProfitLoss
-101097000
CY2023 us-gaap Profit Loss
ProfitLoss
-14241000
CY2021 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-6944000
CY2022 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-9614000
CY2023 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-1806000
CY2023 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-254000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-121524000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-193382000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-99291000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13987000
CY2021 us-gaap Profit Loss
ProfitLoss
-128468000
CY2022 us-gaap Profit Loss
ProfitLoss
-202996000
CY2023 us-gaap Profit Loss
ProfitLoss
-101097000
CY2023 us-gaap Profit Loss
ProfitLoss
-14241000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0
CY2022 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0
CY2023 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3191000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
27160000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6435000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
906000
CY2021 tour Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest And Redeemable Noncontrolling Interests
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAndRedeemableNoncontrollingInterests
-131659000
CY2022 tour Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest And Redeemable Noncontrolling Interests
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAndRedeemableNoncontrollingInterests
-175836000
CY2023 tour Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest And Redeemable Noncontrolling Interests
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAndRedeemableNoncontrollingInterests
-94662000
CY2023 tour Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest And Redeemable Noncontrolling Interests
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAndRedeemableNoncontrollingInterests
-13335000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-6944000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-9614000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1806000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-254000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-124715000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-166222000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-92856000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13081000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
370874312
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
370874312
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
371208209
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
371208209
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
371453164
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3053000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1168000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
5259000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
371453164
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
371453164
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
371453164
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1350015000
CY2021 tour Adjustments To Additional Paid In Capital Acquisition Of Additional Shares In Subsidiaries
AdjustmentsToAdditionalPaidInCapitalAcquisitionOfAdditionalSharesInSubsidiaries
1903000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
356000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9132000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3191000
CY2021 us-gaap Profit Loss
ProfitLoss
-128468000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1225941000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1225941000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
53000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5049000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
27160000
CY2022 tour Adjustments To Additional Paid In Capital Disposal Of Shares In Subsidiaries
AdjustmentsToAdditionalPaidInCapitalDisposalOfSharesInSubsidiaries
-24061000
CY2022 us-gaap Profit Loss
ProfitLoss
-202996000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1031146000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1031146000
CY2023 tour Adjustments To Additional Paid In Capital Acquisition Of Additional Shares In Subsidiaries
AdjustmentsToAdditionalPaidInCapitalAcquisitionOfAdditionalSharesInSubsidiaries
600000
CY2023 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
815000
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
6000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15926000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6435000
CY2023 us-gaap Profit Loss
ProfitLoss
-101097000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
952631000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134175000
CY2021 us-gaap Profit Loss
ProfitLoss
-128468000
CY2022 us-gaap Profit Loss
ProfitLoss
-202996000
CY2023 us-gaap Profit Loss
ProfitLoss
-101097000
CY2023 us-gaap Profit Loss
ProfitLoss
-14241000
CY2021 us-gaap Depreciation
Depreciation
24755000
CY2022 us-gaap Depreciation
Depreciation
15369000
CY2023 us-gaap Depreciation
Depreciation
11895000
CY2023 us-gaap Depreciation
Depreciation
1675000
CY2021 tour Amortization Of Intangible Assets And Land Use Right
AmortizationOfIntangibleAssetsAndLandUseRight
18609000
CY2022 tour Amortization Of Intangible Assets And Land Use Right
AmortizationOfIntangibleAssetsAndLandUseRight
11675000
CY2023 tour Amortization Of Intangible Assets And Land Use Right
AmortizationOfIntangibleAssetsAndLandUseRight
7387000
CY2023 tour Amortization Of Intangible Assets And Land Use Right
AmortizationOfIntangibleAssetsAndLandUseRight
1040000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
20443000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
11119000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
10403000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1465000
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
17829000
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-9844000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-11518000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1622000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3597000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-5519000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-777000
CY2023 tour Impairment Of Long Term Investments
ImpairmentOfLongTermInvestments
22240000
CY2023 tour Impairment Of Long Term Investments
ImpairmentOfLongTermInvestments
3132000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1762000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4964000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9097000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1281000
CY2021 tour Gain Loss From Dividend Of Equity Investments
GainLossFromDividendOfEquityInvestments
5982000
CY2022 tour Gain Loss From Dividend Of Equity Investments
GainLossFromDividendOfEquityInvestments
130000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
9132000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
5049000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
15926000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
2242000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2382000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1741000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-812000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-114000
CY2021 tour Remeasurement Of Equity Investments
RemeasurementOfEquityInvestments
-11443000
CY2022 tour Remeasurement Of Equity Investments
RemeasurementOfEquityInvestments
-5603000
CY2021 tour Increase Decrease In Fair Value Of Investments
IncreaseDecreaseInFairValueOfInvestments
-32687000
CY2022 tour Increase Decrease In Fair Value Of Investments
IncreaseDecreaseInFairValueOfInvestments
-23608000
CY2023 tour Increase Decrease In Fair Value Of Investments
IncreaseDecreaseInFairValueOfInvestments
-25690000
CY2023 tour Increase Decrease In Fair Value Of Investments
IncreaseDecreaseInFairValueOfInvestments
-3618000
CY2022 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
64951000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
112102000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
114661000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16150000
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
17986000
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2533000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
726000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
292000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-580000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-82000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39834000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36996000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3604000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
508000
CY2021 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-8282000
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-8825000
CY2023 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
5362000
CY2023 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
755000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-175139000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-48558000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
62839000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8846000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6058000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2113000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-35276000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4969000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-23507000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-12675000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-20546000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2894000
CY2021 tour Increase Decrease In Accounts And Notes Payable
IncreaseDecreaseInAccountsAndNotesPayable
-222380000
CY2022 tour Increase Decrease In Accounts And Notes Payable
IncreaseDecreaseInAccountsAndNotesPayable
16775000
CY2023 tour Increase Decrease In Accounts And Notes Payable
IncreaseDecreaseInAccountsAndNotesPayable
53125000
CY2023 tour Increase Decrease In Accounts And Notes Payable
IncreaseDecreaseInAccountsAndNotesPayable
7482000
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-16354000
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
31000
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1695000
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
239000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13716000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3776000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5114000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-720000
CY2021 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
2000000
CY2022 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-3646000
CY2023 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
258000
CY2023 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
36000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-68984000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-16589000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
171297000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
24127000
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-9011000
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
11588000
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-7925000
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1116000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-226342000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-142991000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
232838000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32796000
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
336548000
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
462513000
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
606877000
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
85477000
CY2021 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1096550000
CY2022 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
381756000
CY2023 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
579351000
CY2023 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
81600000
CY2021 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
858538000
CY2022 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
825294000
CY2023 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
452974000
CY2023 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
63800000
CY2021 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-724277000
CY2022 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-876608000
CY2023 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-528813000
CY2023 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-74482000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14742000
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6450000
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9788000
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1379000
CY2023 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
1050000
CY2023 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
148000
CY2022 tour Decrease In Cash From Disposals Of Subsidiaries
DecreaseInCashFromDisposalsOfSubsidiaries
16065000
CY2023 tour Decrease In Cash From Disposals Of Subsidiaries
DecreaseInCashFromDisposalsOfSubsidiaries
-3243000
CY2023 tour Decrease In Cash From Disposals Of Subsidiaries
DecreaseInCashFromDisposalsOfSubsidiaries
-457000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Longterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments
86845000
CY2021 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
5982000
CY2022 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
130000
CY2023 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
212000
CY2023 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
30000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
703826000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51828000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
40930000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5765000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
373000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
46000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000
CY2021 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1903000
CY2023 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
600000
CY2023 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
85000
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
620932000
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
240532000
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
400803000
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
56452000
CY2021 tour Proceeds From Shortterm And Longterm Debt
ProceedsFromShorttermAndLongtermDebt
277900000
CY2022 tour Proceeds From Shortterm And Longterm Debt
ProceedsFromShorttermAndLongtermDebt
240000000
CY2023 tour Proceeds From Shortterm And Longterm Debt
ProceedsFromShorttermAndLongtermDebt
378000000
CY2023 tour Proceeds From Shortterm And Longterm Debt
ProceedsFromShorttermAndLongtermDebt
53240000
CY2023 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
815000
CY2023 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
115000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-344562000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-486000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22579000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3181000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1428000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2406000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4185000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-589000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
131494000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-197711000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
247004000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34790000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264104000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
395598000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197887000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27872000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
395598000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197887000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
444891000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62661000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3007000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2199000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1478000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
208000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
7110000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5046000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
4060000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
572000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4429000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6925000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9159000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1290000
CY2021 tour Receivables Related To Exercise Of Stock Options
ReceivablesRelatedToExerciseOfStockOptions
28000
CY2022 tour Receivables Related To Exercise Of Stock Options
ReceivablesRelatedToExerciseOfStockOptions
35000
CY2023 tour Receivables Related To Exercise Of Stock Options
ReceivablesRelatedToExerciseOfStockOptions
32000
CY2023 tour Receivables Related To Exercise Of Stock Options
ReceivablesRelatedToExerciseOfStockOptions
4000
CY2021 tour Accrual Related To Business Acquisition
AccrualRelatedToBusinessAcquisition
7176000
CY2022 tour Accrual Related To Business Acquisition
AccrualRelatedToBusinessAcquisition
4100000
CY2023 tour Accrual Related To Business Acquisition
AccrualRelatedToBusinessAcquisition
4100000
CY2023 tour Accrual Related To Business Acquisition
AccrualRelatedToBusinessAcquisition
577000
CY2021 us-gaap Profit Loss
ProfitLoss
-128468000
CY2022 tour Business Combination Contingent Consideration Increase Decrease In Fair Value
BusinessCombinationContingentConsiderationIncreaseDecreaseInFairValue
-3053000
CY2023 tour Business Combination Contingent Consideration Increase Decrease In Fair Value
BusinessCombinationContingentConsiderationIncreaseDecreaseInFairValue
0
CY2023 tour Business Combination Contingent Consideration Increase Decrease In Fair Value
BusinessCombinationContingentConsiderationIncreaseDecreaseInFairValue
0
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4100000
CY2022 us-gaap Profit Loss
ProfitLoss
-202996000
CY2023 us-gaap Profit Loss
ProfitLoss
-101097000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-226342000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-142991000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
232838000
CY2023Q4 tour Working Capital
WorkingCapital
549239000
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
8099000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;">(c) Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Group’s consolidated financial statements in conformity with the U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities. Actual results could differ materially from those estimates. Significant accounting estimates reflected in the Group’s consolidated financial statements mainly include fair value of short-term and long-term investments, current expected credit losses for financial assets measured at amortized cost, estimated useful lives of property and equipment and intangible assets, impairment for goodwill, impairment for non-financial assets, fair value of contingent considerations with respect to business combinations, fair value of share-based payment arrangements, fair value of initial and subsequent measurement of equity investments using measurement alternative, valuation allowance for deferred tax assets and the determination of uncertain tax positions.</p>
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
7.0999
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
7153000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4100000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
577000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4100000
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2022Q2 us-gaap Goodwill Fair Value Disclosure
GoodwillFairValueDisclosure
1092900000
CY2022Q2 tour Goodwill Carrying Value Before Impairment Loss
GoodwillCarryingValueBeforeImpairmentLoss
1205000000.0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
112100000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
577000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349077000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153835000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
378989000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53379000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
46521000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
44052000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
65902000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9282000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
395598000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197887000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
444891000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62661000
CY2022Q2 tour Goodwill Reduction
GoodwillReduction
119900000
CY2022 tour Increase In Goodwill Market Capitalization
IncreaseInGoodwillMarketCapitalization
1289100000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2022Q4 us-gaap Goodwill Fair Value Disclosure
GoodwillFairValueDisclosure
1058300000
CY2023Q4 tour Market Capitalization Of Company
MarketCapitalizationOfCompany
83100000
CY2023Q4 tour Percentage By Which Net Assets Exceeds Market Capitalization Value
PercentageByWhichNetAssetsExceedsMarketCapitalizationValue
0.47
CY2022 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13216000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1530000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
5189000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
91422000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
94433000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
80547000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11345000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13216000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
844000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
350000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
49000
CY2022 tour Allowance For Doubtful Accounts Reversal
AllowanceForDoubtfulAccountsReversal
-2374000
CY2023 tour Allowance For Doubtful Accounts Reversal
AllowanceForDoubtfulAccountsReversal
-5539000
CY2023 tour Allowance For Doubtful Accounts Reversal
AllowanceForDoubtfulAccountsReversal
-780000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
10205000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2752000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
388000
CY2022 tour Accounts Receivable Allowance For Credit Loss Disposals Of Subsidiaries
AccountsReceivableAllowanceForCreditLossDisposalsOfSubsidiaries
-12356000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
94433000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
80547000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
72606000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10226000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
114700000
CY2023Q4 us-gaap Goodwill
Goodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 tour Land Use Rights Net
LandUseRightsNet
90500000
CY2023 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
22240000
CY2021 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2022 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023Q4 tour Land Use Right And Construction In Progress Market Value
LandUseRightAndConstructionInProgressMarketValue
121100000
CY2023 tour Land Use Right And Construction In Progress Amount By Which Market Value Is Lesser Than Gross Carrying Amount
LandUseRightAndConstructionInProgressAmountByWhichMarketValueIsLesserThanGrossCarryingAmount
18000000.0
CY2023Q4 tour Land Use Right And Construction In Progress Gross Carrying Amount
LandUseRightAndConstructionInProgressGrossCarryingAmount
139100000
CY2023 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
18000000.0
tour Impairment On Non Financial Assets
ImpairmentOnNonFinancialAssets
0
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1120000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
399000
CY2021 tour Commission Fees From Travel Related Products And Services
CommissionFeesFromTravelRelatedProductsAndServices
38406000
CY2022 tour Commission Fees From Travel Related Products And Services
CommissionFeesFromTravelRelatedProductsAndServices
46263000
CY2023 tour Commission Fees From Travel Related Products And Services
CommissionFeesFromTravelRelatedProductsAndServices
44647000
CY2022Q4 tour Accrued Liabilities Related To Customer Incentive Programs Current
AccruedLiabilitiesRelatedToCustomerIncentiveProgramsCurrent
3400000
CY2023Q4 tour Accrued Liabilities Related To Customer Incentive Programs Current
AccruedLiabilitiesRelatedToCustomerIncentiveProgramsCurrent
3700000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
40661000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
15066000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
15066000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
50325000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
22326000
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
17367000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13413000
CY2021 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
576165
CY2022 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
314592
CY2023 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
151485
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q4 tour Business Combination Unpaid Consideration
BusinessCombinationUnpaidConsideration
4100000
CY2022Q4 us-gaap Supplies
Supplies
45212000
CY2023Q4 us-gaap Supplies
Supplies
141585000
CY2023Q4 us-gaap Supplies
Supplies
19942000
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
843000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
603000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
85000
CY2022Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
406000
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
1014000
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
143000
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
100361000
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
25130000
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
3539000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
62808000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
46269000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
6517000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
20766000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
11967000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1686000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
242994000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
234189000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32985000
CY2021 tour Prepayments And Other Current Assets Allowance For Credit Loss Expense Reversal
PrepaymentsAndOtherCurrentAssetsAllowanceForCreditLossExpenseReversal
2858000
CY2022 tour Prepayments And Other Current Assets Allowance For Credit Loss Expense Reversal
PrepaymentsAndOtherCurrentAssetsAllowanceForCreditLossExpenseReversal
8458000
CY2023 tour Prepayments And Other Current Assets Allowance For Credit Loss Expense Reversal
PrepaymentsAndOtherCurrentAssetsAllowanceForCreditLossExpenseReversal
2923000
CY2023Q4 tour Net Cumulative Fair Value Adjustments
NetCumulativeFairValueAdjustments
-6631000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
49502000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
71741000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
10104000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
54362000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
54833000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
7723000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
172563000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
150112000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
21143000
CY2022Q4 tour Equity Securities With Readily Determinable Fair Value Amount
EquitySecuritiesWithReadilyDeterminableFairValueAmount
889000
CY2023Q4 tour Equity Securities With Readily Determinable Fair Value Amount
EquitySecuritiesWithReadilyDeterminableFairValueAmount
1865000
CY2023Q4 tour Equity Securities With Readily Determinable Fair Value Amount
EquitySecuritiesWithReadilyDeterminableFairValueAmount
263000
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
2748000
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3009000
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
424000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
230562000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
209819000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
29552000
CY2022Q4 tour Initial Cost Of Equity Investments Without Readily Determinable Fair Values
InitialCostOfEquityInvestmentsWithoutReadilyDeterminableFairValues
174983000
CY2023Q4 tour Initial Cost Of Equity Investments Without Readily Determinable Fair Values
InitialCostOfEquityInvestmentsWithoutReadilyDeterminableFairValues
174771000
CY2023Q4 tour Initial Cost Of Equity Investments Without Readily Determinable Fair Values
InitialCostOfEquityInvestmentsWithoutReadilyDeterminableFairValues
24616000
CY2022Q4 tour Net Cumulative Fair Value Adjustments
NetCumulativeFairValueAdjustments
-47082000
CY2023Q4 tour Net Cumulative Fair Value Adjustments
NetCumulativeFairValueAdjustments
-47082000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
172563000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
150112000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
21143000
CY2023 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
22240000
CY2021 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
2748000
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3009000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
455534000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
438692000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
61789000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
417644000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
411963000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58024000
CY2022Q4 tour Property Plant And Equipment Gross Before Construction In Progress
PropertyPlantAndEquipmentGrossBeforeConstructionInProgress
37890000
CY2023Q4 tour Property Plant And Equipment Gross Before Construction In Progress
PropertyPlantAndEquipmentGrossBeforeConstructionInProgress
26729000
CY2023Q4 tour Property Plant And Equipment Gross Before Construction In Progress
PropertyPlantAndEquipmentGrossBeforeConstructionInProgress
3765000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
47292000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
48736000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
6864000
CY2023Q4 tour Property Plant And Equipment Accumulated Impairment
PropertyPlantAndEquipmentAccumulatedImpairment
17986000
CY2023Q4 tour Property Plant And Equipment Accumulated Impairment
PropertyPlantAndEquipmentAccumulatedImpairment
2533000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85182000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57479000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8096000
CY2022Q4 us-gaap Goodwill
Goodwill
16150000
CY2022 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-5244000
CY2023 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
0
CY2023 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
112102000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
114661000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16150000
CY2022Q4 us-gaap Goodwill
Goodwill
114661000
CY2023Q4 us-gaap Goodwill
Goodwill
0
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
166552000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
167255000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23558000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
113558000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
118842000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16739000
CY2022Q4 tour Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
22322000
CY2023Q4 tour Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
22322000
CY2023Q4 tour Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
3144000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30672000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26091000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3675000
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4169000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
587000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2903000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
409000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2422000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
341000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2377000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
335000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1914000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
270000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
12306000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1733000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26091000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3675000
CY2023Q4 us-gaap Goodwill
Goodwill
0
CY2022Q4 tour Land Use Right Gross
LandUseRightGross
101007000
CY2023Q4 tour Land Use Right Gross
LandUseRightGross
101007000
CY2023Q4 tour Land Use Right Gross
LandUseRightGross
14227000
CY2022Q4 tour Land Use Right Accumulated Amortization
LandUseRightAccumulatedAmortization
8417000
CY2023Q4 tour Land Use Right Accumulated Amortization
LandUseRightAccumulatedAmortization
10478000
CY2023Q4 tour Land Use Right Accumulated Amortization
LandUseRightAccumulatedAmortization
1476000
CY2022Q4 tour Land Use Rights Net
LandUseRightsNet
92590000
CY2023Q4 tour Land Use Rights Net
LandUseRightsNet
90529000
CY2023Q4 tour Land Use Rights Net
LandUseRightsNet
12751000
CY2021 tour Land Use Right Amortization
LandUseRightAmortization
2062000
CY2022 tour Land Use Right Amortization
LandUseRightAmortization
2062000
CY2023 tour Land Use Right Amortization
LandUseRightAmortization
2061000
CY2021Q4 us-gaap Goodwill
Goodwill
232007000
CY2022Q4 us-gaap Goodwill
Goodwill
114661000
CY2022Q4 tour Rental Deposits Non Current
RentalDepositsNonCurrent
1836000
CY2023Q4 tour Rental Deposits Non Current
RentalDepositsNonCurrent
1813000
CY2023Q4 tour Rental Deposits Non Current
RentalDepositsNonCurrent
255000
CY2022Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
9795000
CY2023Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
8551000
CY2023Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
1204000
CY2022Q4 tour Prepayments To Suppliers Non Current
PrepaymentsToSuppliersNonCurrent
62663000
CY2023Q4 tour Prepayments To Suppliers Non Current
PrepaymentsToSuppliersNonCurrent
29341000
CY2023Q4 tour Prepayments To Suppliers Non Current
PrepaymentsToSuppliersNonCurrent
4133000
CY2022Q4 tour Receivables For Disposal Of Subsidiaries Non Current
ReceivablesForDisposalOfSubsidiariesNonCurrent
6373000
CY2023Q4 tour Receivables For Disposal Of Subsidiaries Non Current
ReceivablesForDisposalOfSubsidiariesNonCurrent
5850000
CY2023Q4 tour Receivables For Disposal Of Subsidiaries Non Current
ReceivablesForDisposalOfSubsidiariesNonCurrent
824000
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
10424000
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
10405000
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1466000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91091000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55960000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7882000
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1092000
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
2979000
CY2023 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
283000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9852000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10944000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7965000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1122000
CY2021 tour Financing Receivable Allowance For Credit Loss Addition
FinancingReceivableAllowanceForCreditLossAddition
1633000
CY2022 tour Financing Receivable Allowance For Credit Loss Addition
FinancingReceivableAllowanceForCreditLossAddition
1894000
CY2023 tour Financing Receivable Allowance For Credit Loss Addition
FinancingReceivableAllowanceForCreditLossAddition
682000
CY2023 tour Financing Receivable Allowance For Credit Loss Addition
FinancingReceivableAllowanceForCreditLossAddition
96000
CY2021 tour Financing Receivable Allowance For Credit Loss Reversal
FinancingReceivableAllowanceForCreditLossReversal
-541000
CY2022 tour Financing Receivable Allowance For Credit Loss Reversal
FinancingReceivableAllowanceForCreditLossReversal
-4873000
CY2023 tour Financing Receivable Allowance For Credit Loss Reversal
FinancingReceivableAllowanceForCreditLossReversal
-965000
CY2023 tour Financing Receivable Allowance For Credit Loss Reversal
FinancingReceivableAllowanceForCreditLossReversal
-136000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10944000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7965000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7682000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1082000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
7517000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
7277000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1025000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11959000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10395000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1464000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5201000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2370000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1130000
CY2023Q4 tour Long Term Debt Maturity Year Five And Thereafter
LongTermDebtMaturityYearFiveAndThereafter
1694000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
10395000
CY2021 us-gaap Lease Cost
LeaseCost
26469000
CY2022 us-gaap Lease Cost
LeaseCost
15427000
CY2023 us-gaap Lease Cost
LeaseCost
12511000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2540000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1936000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
809000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33204000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12484000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1758000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12439000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2709000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
382000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26482000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5348000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
753000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
38921000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8057000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1135000
CY2021 tour Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
26000000
CY2022 tour Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
15048000
CY2023 tour Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
15169000
CY2023 tour Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
2136000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
43855000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5642000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8619000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1214000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y29D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y25D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2023 us-gaap Short Term Lease Payments
ShortTermLeasePayments
286000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2676000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2112000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2089000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2003000
CY2023Q4 tour Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
1127000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10007000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1950000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8057000
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
10474000
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
10386000
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1463000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4100000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4100000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
577000
CY2022Q4 tour Accrued Liabilities Related To Customer Incentive Programs Current
AccruedLiabilitiesRelatedToCustomerIncentiveProgramsCurrent
3400000
CY2023Q4 tour Accrued Liabilities Related To Customer Incentive Programs Current
AccruedLiabilitiesRelatedToCustomerIncentiveProgramsCurrent
3700000
CY2023Q4 tour Accrued Liabilities Related To Customer Incentive Programs Current
AccruedLiabilitiesRelatedToCustomerIncentiveProgramsCurrent
521000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11356000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3298000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
465000
CY2022Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
16047000
CY2023Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
15885000
CY2023Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
2237000
CY2022Q4 tour Deposits Liability From Suppliers Current
DepositsLiabilityFromSuppliersCurrent
72169000
CY2023Q4 tour Deposits Liability From Suppliers Current
DepositsLiabilityFromSuppliersCurrent
64401000
CY2023Q4 tour Deposits Liability From Suppliers Current
DepositsLiabilityFromSuppliersCurrent
9071000
CY2022Q4 tour Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
7662000
CY2023Q4 tour Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
16535000
CY2023Q4 tour Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
2329000
CY2022Q4 tour Advanced Payment From Banks Current
AdvancedPaymentFromBanksCurrent
13577000
CY2023Q4 tour Advanced Payment From Banks Current
AdvancedPaymentFromBanksCurrent
14085000
CY2023Q4 tour Advanced Payment From Banks Current
AdvancedPaymentFromBanksCurrent
1984000
CY2022Q4 tour Discounted Bank Acceptance Notes Current
DiscountedBankAcceptanceNotesCurrent
200000000
CY2023Q4 tour Discounted Bank Acceptance Notes Current
DiscountedBankAcceptanceNotesCurrent
179000000
CY2023Q4 tour Discounted Bank Acceptance Notes Current
DiscountedBankAcceptanceNotesCurrent
25212000
CY2022Q4 tour Other Accrued Expenses And Other Current Liabilities Miscellaneous Current
OtherAccruedExpensesAndOtherCurrentLiabilitiesMiscellaneousCurrent
19527000
CY2023Q4 tour Other Accrued Expenses And Other Current Liabilities Miscellaneous Current
OtherAccruedExpensesAndOtherCurrentLiabilitiesMiscellaneousCurrent
18091000
CY2023Q4 tour Other Accrued Expenses And Other Current Liabilities Miscellaneous Current
OtherAccruedExpensesAndOtherCurrentLiabilitiesMiscellaneousCurrent
2549000
CY2022Q4 tour Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
358312000
CY2023Q4 tour Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
329481000
CY2023Q4 tour Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
46408000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.250
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.250
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.250
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.160
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.203
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.241
CY2021 tour Effective Income Tax Rate Reconciliation Research And Development Super Deduction Percent
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentSuperDeductionPercent
-0.043
CY2022 tour Effective Income Tax Rate Reconciliation Research And Development Super Deduction Percent
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentSuperDeductionPercent
-0.029
CY2023 tour Effective Income Tax Rate Reconciliation Research And Development Super Deduction Percent
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentSuperDeductionPercent
0.036
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.011
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.004
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.485
CY2021 tour Effective Income Tax Rate Reconciliation Difference In Earned Income Tax Rates Of Subsidiary
EffectiveIncomeTaxRateReconciliationDifferenceInEarnedIncomeTaxRatesOfSubsidiary
-0.003
CY2022 tour Effective Income Tax Rate Reconciliation Difference In Earned Income Tax Rates Of Subsidiary
EffectiveIncomeTaxRateReconciliationDifferenceInEarnedIncomeTaxRatesOfSubsidiary
0.001
CY2023 tour Effective Income Tax Rate Reconciliation Difference In Earned Income Tax Rates Of Subsidiary
EffectiveIncomeTaxRateReconciliationDifferenceInEarnedIncomeTaxRatesOfSubsidiary
0.007
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.034
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.019
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.063
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.014
CY2021 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
4411000
CY2022 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
3929000
CY2023 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
6245000
CY2023 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
880000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
15393000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
7246000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1021000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
483092000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
403448000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
56825000
CY2022Q4 tour Deferred Tax Assets Tax Deferred Expense Reserves And Accrual Carryforwards Of Deductible Advertising Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualCarryforwardsOfDeductibleAdvertisingExpenses
11349000
CY2023Q4 tour Deferred Tax Assets Tax Deferred Expense Reserves And Accrual Carryforwards Of Deductible Advertising Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualCarryforwardsOfDeductibleAdvertisingExpenses
10617000
CY2023Q4 tour Deferred Tax Assets Tax Deferred Expense Reserves And Accrual Carryforwards Of Deductible Advertising Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualCarryforwardsOfDeductibleAdvertisingExpenses
1495000
CY2023Q4 tour Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Of Financial Assets
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentOfFinancialAssets
4496000
CY2023Q4 tour Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Of Financial Assets
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentOfFinancialAssets
633000
CY2022Q4 tour Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Re Measurement And Impairment Of Long Term Investments
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReMeasurementAndImpairmentOfLongTermInvestments
362000
CY2023Q4 tour Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Re Measurement And Impairment Of Long Term Investments
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReMeasurementAndImpairmentOfLongTermInvestments
3699000
CY2023Q4 tour Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Re Measurement And Impairment Of Long Term Investments
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReMeasurementAndImpairmentOfLongTermInvestments
521000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
246930000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
242704000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
34184000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
757126000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
672210000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
94679000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
757126000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
672210000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
94679000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
6839000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
6027000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
849000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6839000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6027000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
849000
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1946016000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
757126000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
672210000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1332721000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
939621000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
757126000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
106639000
CY2021 tour Deferred Tax Assets Valuation Allowance Additions
DeferredTaxAssetsValuationAllowanceAdditions
29089000
CY2022 tour Deferred Tax Assets Valuation Allowance Additions
DeferredTaxAssetsValuationAllowanceAdditions
31686000
CY2023 tour Deferred Tax Assets Valuation Allowance Additions
DeferredTaxAssetsValuationAllowanceAdditions
18027000
CY2023 tour Deferred Tax Assets Valuation Allowance Additions
DeferredTaxAssetsValuationAllowanceAdditions
2539000
CY2021 tour Valuation Allowance Deferred Tax Asset Decrease Written Off For Expiration Of Net Operating Losses
ValuationAllowanceDeferredTaxAssetDecreaseWrittenOffForExpirationOfNetOperatingLosses
414409000
CY2022 tour Valuation Allowance Deferred Tax Asset Decrease Written Off For Expiration Of Net Operating Losses
ValuationAllowanceDeferredTaxAssetDecreaseWrittenOffForExpirationOfNetOperatingLosses
212636000
CY2023 tour Valuation Allowance Deferred Tax Asset Decrease Written Off For Expiration Of Net Operating Losses
ValuationAllowanceDeferredTaxAssetDecreaseWrittenOffForExpirationOfNetOperatingLosses
60924000
CY2023 tour Valuation Allowance Deferred Tax Asset Decrease Written Off For Expiration Of Net Operating Losses
ValuationAllowanceDeferredTaxAssetDecreaseWrittenOffForExpirationOfNetOperatingLosses
8581000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-7780000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1545000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-42019000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-5918000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
939621000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
757126000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
672210000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
94679000
CY2016Q4 tour Proceeds From Redeemable Noncontrollinginterest
ProceedsFromRedeemableNoncontrollinginterest
90000000
CY2020 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
77733000
CY2020 tour Ownership Percentage Of Redeemable Noncontrolling Interest Purchased
OwnershipPercentageOfRedeemableNoncontrollingInterestPurchased
0.20
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27200000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27200000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27200000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
3831000
CY2021 tour Contribution From Acquisition Of Redeemable Noncontrolling Interests
ContributionFromAcquisitionOfRedeemableNoncontrollingInterests
0
CY2022 tour Contribution From Acquisition Of Redeemable Noncontrolling Interests
ContributionFromAcquisitionOfRedeemableNoncontrollingInterests
0
CY2023 tour Contribution From Acquisition Of Redeemable Noncontrolling Interests
ContributionFromAcquisitionOfRedeemableNoncontrollingInterests
0
CY2023 tour Contribution From Acquisition Of Redeemable Noncontrolling Interests
ContributionFromAcquisitionOfRedeemableNoncontrollingInterests
0
CY2021 us-gaap Temporary Equity Accretion Of Interest
TemporaryEquityAccretionOfInterest
0
CY2022 us-gaap Temporary Equity Accretion Of Interest
TemporaryEquityAccretionOfInterest
0
CY2023 us-gaap Temporary Equity Accretion Of Interest
TemporaryEquityAccretionOfInterest
0
CY2023 us-gaap Temporary Equity Accretion Of Interest
TemporaryEquityAccretionOfInterest
0
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27200000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27200000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27200000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
3831000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022 tour Common Stock Value Authorized
CommonStockValueAuthorized
100000000
CY2023 tour Common Stock Value Authorized
CommonStockValueAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
100000000
CY2023Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
100000000
CY2022Q4 tour Excess Common Stock Par Or Stated Value Per Share
ExcessCommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 tour Excess Common Stock Par Or Stated Value Per Share
ExcessCommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
389331543
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.15
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.27
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-121524000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-193382000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-99291000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13987000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-121524000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-193382000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-99291000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13987000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
370874312
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
370874312
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
371208209
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
371208209
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
371453164
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
371453164
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
371453164
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
371453164
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2891152
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9996757
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9728646
CY2023 tour Appropriation Of After Tax Income To Statutory General Reserve Per Annum
AppropriationOfAfterTaxIncomeToStatutoryGeneralReservePerAnnum
0.10
CY2023Q4 tour Reserve Level Threshold For Mandatory Transfer Percentage
ReserveLevelThresholdForMandatoryTransferPercentage
0.50
CY2023Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
647559000000
CY2023 tour Percentage On Total Consolidated Net Assets
PercentageOnTotalConsolidatedNetAssets
0.661
CY2023Q4 us-gaap Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
791000
CY2022Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
30400000
CY2023Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
30000000.0
CY2022Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
30400000
CY2023Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
30000000.0
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
17951931
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
17800446

Files In Submission

Name View Source Status
0001104659-24-053505-index-headers.html Edgar Link pending
0001104659-24-053505-index.html Edgar Link pending
0001104659-24-053505.txt Edgar Link pending
0001104659-24-053505-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tour-20231231.xsd Edgar Link pending
tour-20231231x20f.htm Edgar Link pending
tour-20231231x20f003.jpg Edgar Link pending
tour-20231231x20f004.jpg Edgar Link pending
tour-20231231x20f005.jpg Edgar Link pending
tour-20231231x20f006.jpg Edgar Link pending
tour-20231231x20f007.jpg Edgar Link pending
tour-20231231xex11d1.htm Edgar Link pending
tour-20231231xex12d1.htm Edgar Link pending
tour-20231231xex12d2.htm Edgar Link pending
tour-20231231xex13d1.htm Edgar Link pending
tour-20231231xex13d2.htm Edgar Link pending
tour-20231231xex15d1.htm Edgar Link pending
tour-20231231xex15d2.htm Edgar Link pending
tour-20231231xex15d2001.jpg Edgar Link pending
tour-20231231xex15d2002.jpg Edgar Link pending
tour-20231231xex15d3.htm Edgar Link pending
tour-20231231xex15d3001.jpg Edgar Link pending
tour-20231231xex4d3.htm Edgar Link pending
tour-20231231xex8d1.htm Edgar Link pending
tour-20231231xex97d1.htm Edgar Link pending
tour-20231231_lab.xml Edgar Link unprocessable
tour-20231231x20f_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
tour-20231231_pre.xml Edgar Link unprocessable
tour-20231231_cal.xml Edgar Link unprocessable
tour-20231231_def.xml Edgar Link unprocessable